Bearish
Mangoceuticals (NASDAQ: MGRX) Q1 2026 shows small sales, heavy loss and thin cash
Mangoceuticals Inc. reported a Q1 2026 net loss of $3.4 million on revenues of $67,864, down from the prior year, with significant spending on operati...